Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Verve Therapeutics
Via GlobeNewswire
News headline image
3 Stocks That Could Be the Next Big Thing in Gene Editing ↗
Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks. 
Via InvestorPlace
News headline image
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Verve Therapeutics
Via GlobeNewswire
News headline image
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug ↗
Both companies are working on treatments for genetic disorders. 
Via Investor's Business Daily
News headline image
Verve Therapeutics: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Why Verve Therapeutics Stock Crashed as Much as 30% This Week ↗
There was a concerning development in the company's clinical trials. 
Via The Motley Fool
News headline image
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
From Verve Therapeutics
Via GlobeNewswire
News headline image
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
Biotech stocks, namely those involved with gene editing, have been explosive and could see higher highs with strong catalysts. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks With Unprecedented Surge Potential ↗
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. 
Via InvestorPlace
News headline image
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare ↗
It's less scary to take on risky investments when the market is rising. 
Via The Motley Fool
News headline image
Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Verve Therapeutics
Via GlobeNewswire
News headline image
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential ↗
Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example. 
Via InvestorPlace
News headline image
Why Beam Therapeutics Stock Zoomed 17% Higher Today ↗
JPMorgan Chase becomes the latest institution in the company's bull pen. 
Via The Motley Fool
News headline image
7 Mighty Healthcare Stocks Changing the Game of Medicine ↗
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks. 
Via InvestorPlace
News headline image
3 Stocks to Buy in the Booming Field of Gene Editing ↗
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains. 
Via InvestorPlace
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
Via Investor's Business Daily
News headline image
Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Verve Therapeutics
Via GlobeNewswire
News headline image
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics ↗
Curing rare inherited illnesses could be a lucrative business model. 
Via The Motley Fool
News headline image
$18M Bet On Verve Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. ↗
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach. 
Via The Motley Fool
News headline image
Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement
From Verve Therapeutics
Via GlobeNewswire
News headline image
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS... 
Via Benzinga
News headline image
Why Verve Therapeutics Stock (VERV) Is Falling ↗
Verve Therapeutics Inc (NASDAQ: VERV) shares are trading lower by 6.3% to $11.18 Wednesday morning after the company priced its proposed public offering of common stock and  
Via Benzinga
News headline image
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
Shares of Workday, Inc. (NASDAQ: WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning! 
Via InvestorPlace
News headline image
Leslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 100 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
From Verve Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
From Verve Therapeutics
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.